跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CRESEMBA 40 MG CAPSULAS DURAS - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
CRESEMBA 40 MG CAPSULAS DURAS
Approved
STANDARD
CRESEMBA 40 MG CAPSULAS DURAS
Basilea Pharmaceutica Deutschland Gmbh
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Oct 3, 2024
Approval ID
8d6c266b80a61b65
Company
Basilea Pharmaceutica Deutschland Gmbh
Type
Standard
Approval Details
Approval Id
8d6c266b80a61b65
Drug Cima Aemps Name
CRESEMBA 40 MG CAPSULAS DURAS
Register Number
1151036003
Holder Company Name
Basilea Pharmaceutica Deutschland Gmbh
Marketing Company Name
Pfizer S.L.
Holder Company Detail Path
/organization/basilea-pharmaceutica-deutschland-gmbh
Authorization Date
2024-10-03
Dosage Form
CÁPSULA DURA
Dose
40 mg
Route Of Administration
VÍA ORAL
Prescription Type
Uso Hospitalario
Commercialized
Yes
Company Name
Basilea Pharmaceutica Deutschland Gmbh
Company Detail Path
/organization/basilea-pharmaceutica-deutschland-gmbh
Company Information
Pharmaceutical Company Name
Basilea Pharmaceutica Deutschland GmbH
Country Name
Germany
City Name
lörrach,baden-württemberg,country_de
Address
Marie-Curie-Str. 8
Active Ingredients
ISAVUCONAZOL SULFATO
74,5 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Oct 3, 2024
Approval ID
8d6c266b80a61b65
Type
Standard
Back to CIMA-AEMPS Approvals